Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
Details : Vilazodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Depressive Disorder, Major.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 06, 2015
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)
Details : Vilazodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Depressive Disorder, Major.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 26, 2015
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vilazodone
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Vilazodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 26, 2014
Lead Product(s) : Vilazodone
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase IV
Sponsor : Forest Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Vilazodone for Separation Anxiety Disorder
Details : Vilazodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Anxiety, Separation.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 03, 2013
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Sponsor : Forest Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Details : Vilazodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Depressive Disorder, Major.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 14, 2013
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase IV
Sponsor : Forest Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?
Details : Vilazodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Sexual Dysfunction.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 17, 2013
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Sponsor : Forest Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
Details : Vilazodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Generalized Anxiety Disorder.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 01, 2013
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vilazodone
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Forest Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Vilazodone for Corticosteroid-Induced Memory Impairment
Details : Vilazodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Memory Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 10, 2013
Lead Product(s) : Vilazodone
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Forest Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Details : Vilazodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Generalized Anxiety Disorder.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 11, 2013
Lead Product(s) : Vilazodone
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vilazodone Hydrochloride,Vilazodone
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase IV
Sponsor : Forest Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Vilazodone for the Treatment of Posttraumatic Stress Disorder
Details : Viibryd (Vilazodone) is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Stress Disorders, Post-Traumatic.
Product Name : Viibryd
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 29, 2012
Lead Product(s) : Vilazodone Hydrochloride,Vilazodone
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Sponsor : Forest Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
